3 hours ago
1
Torsten Asmus/iStock via Getty Images
- Legend Biotech (NASDAQ:LEGN) is said to be weighing a secondary listing of its stock in a market outside of the US.
- Hong Kong, London, and Singapore exchanges are being considered, according to a report in Bloomberg.
- Although the company has
English (US) ·